PHARMACISTS working at Royal Hobart Hospital have received a significant funding boost, with the Tasmanian Government announcing $3.8 million for the redevelopment of the hospital's pharmacy.
Tasmanian Treasurer, Peter Gutwien, announced the measure alongside an additional $352.6 million in hospital infrastructure upgrades.
Welcoming the funding for the redevelopment of the hospital's pharmacy, Society of Hospital Pharmacists of Australia (SHPA) President, Peter Fowler, said it would increase the capacity for hospital pharmacists to support chemotherapy & elective surgeries in the public health system.
"As a representative of hospital pharmacy, and as a Tasmanian, I welcome the $3.8 million over two years toward the Royal Hobart Hospital pharmacy redevelopment, which will see the construction of a news sterile pharmaceutical production facility," he said.
"From the perspective of treatment safety and quality we commend the Tasmanian Government for this strong investment into this crucial aspect of cancer treatment, which will help ensure more chemotherapy services can be delivered in the public hospital system, which is important for equity of patient access," Fowler said.
"As custodians of a substantial proportion of PBS medicines, including cutting-edge chemotherapies for inpatients with cancer, it is appropriate to see commensurate investment in the facilities hospital pharmacists need to deliver these essential services."
The above article was sent to subscribers in Pharmacy Daily's issue from 28 May 19
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 28 May 19
